Science Explorer Back to mapMap
Discussion
Research facility · Nedlands · Australia

Linear Clinical Research

linear.org.auROR OpenAlex
Research works
74
▲ 58% vs 2018-21
Citations
888
12.0 per fractional work
Top-10% rate
14.2%
all institutions 10.0%
Open access
48%
world 40%
International
59%
world 18%
Linear Clinical Research

Not ranked overall: Linear Clinical Research is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Linear Clinical Research work in?

In 2022-now, 72% of research at Linear Clinical Research is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (71%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (8%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 22 fractional works · 71.7% of its workMedicine: 21 fractional works · 71.0% of its workOncology: 7 fractional works · 23.5% of its workPathology and Forensic Medicine: 2 fractional works · 8.0% of its workGenetics: 2 fractional works · 7.9% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 6.9% of its workPulmonary and Respiratory Medicine: 2 fractional works · 5.9% of its workHematology: 1 fractional works · 3.4% of its workNeurology: 1 fractional works · 2.3% of its workDermatology: 1 fractional works · 1.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.6% of its workSurgery: 0 fractional works · 1.2% of its workImmunology and Allergy: 0 fractional works · 1.1% of its workPsychiatry and Mental health: 0 fractional works · 0.8% of its workOtorhinolaryngology: 0 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.7% of its workComplementary and alternative medicine: 0 fractional works · 0.6% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.6% of its workRehabilitation: 0 fractional works · 0.6% of its workEpidemiology: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.4% of its workReproductive Medicine: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.3% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.2% of its workRheumatology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workVeterinary: 0 fractional works · 0.7% of its workEquine: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Professions: 0 fractional works · 0.0% of its workLife Sciences: 7 fractional works · 23.8% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 13.4% of its workMolecular Biology: 2 fractional works · 8.1% of its workCancer Research: 1 fractional works · 2.7% of its workCell Biology: 0 fractional works · 1.2% of its workBiotechnology: 0 fractional works · 0.7% of its workGenetics: 0 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 2 fractional works · 7.7% of its workImmunology: 2 fractional works · 7.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 1.6% of its workNeurology: 0 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.4% of its workAnimal Science and Zoology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.3% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 3.2% of its workSocial Sciences: 0 fractional works · 1.1% of its workCultural Studies: 0 fractional works · 0.6% of its workGeography, Planning and Development: 0 fractional works · 0.6% of its workPsychology: 0 fractional works · 0.8% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.6% of its workClinical Psychology: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.8% of its workEconomics and Econometrics: 0 fractional works · 0.8% of its workArts and Humanities: 0 fractional works · 0.6% of its workArcheology: 0 fractional works · 0.6% of its workPhysical Sciences: 0 fractional works · 1.3% of its workEngineering: 0 fractional works · 0.6% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.3% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.3% of its workBiomaterials: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workALL ITS WORKLinear ClinicalResearch30fractional works, 2022-now
Life Sciences24%Physical Sciences1%Health Sciences72%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine2171.0%
    2. Veterinary00.7%
    3. Health Professions00.0%
    1. Biochemistry, Genetics and Molecular Biology413.4%
    2. Immunology and Microbiology27.7%
    3. Neuroscience01.6%
    4. Agricultural and Biological Sciences00.8%
    5. Pharmacology, Toxicology and Pharmaceutics00.3%
    1. Social Sciences01.1%
    2. Psychology00.8%
    3. Economics, Econometrics and Finance00.8%
    4. Arts and Humanities00.6%
    1. Engineering00.6%
    2. Chemistry00.3%
    3. Materials Science00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.16× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.51× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 7.67× its world share, 2 worksImmunology and Micro…Neuroscience: 1.00× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.81× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.20× its world share, 0 worksChemistryEngineering: 0.04× its world share, 0 worksEngineeringMaterials Science: 0.09× its world share, 0 worksMaterials ScienceHealth Professions: 0.02× its world share, 0 worksHealth ProfessionsMedicine: 3.70× its world share, 22 worksMedicineVeterinary: 4.79× its world share, 0 worksVeterinaryArts and Humanities: 0.19× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.35× its world share, 0 worksEconomics, Econometr…Psychology: 0.26× its world share, 0 worksPsychologySocial Sciences: 0.09× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.7×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Immunology and Microbiology7.67×2 works
  2. Veterinary4.79×0 works
  3. Medicine3.70×22 works
  4. Biochemistry, Genetics and Molecular Biology2.51×4 works
  5. Neuroscience1.00×0 works
  6. Pharmacology, Toxicology and Pharmaceutics0.81×0 works
  7. Economics, Econometrics and Finance0.35×0 works
  8. Psychology0.26×0 works
  9. Chemistry0.20×0 works
  10. Arts and Humanities0.19×0 works
  11. Agricultural and Biological Sciences0.16×0 works
  12. Materials Science0.09×0 works
  13. Social Sciences0.09×0 works
  14. Engineering0.04×0 works
  15. Health Professions0.02×0 works

Who are the top researchers at Linear Clinical Research?

Ranked on the quality score, Janakan Krishnarajah and Timothy Guy Humphries lead among researchers whose main affiliation is Linear Clinical Research.

  1. 1 Janakan Krishnarajah Australia · #1,641,414 worldwide 519 citations · 15 works
  2. 2 Timothy Guy Humphries Australia · #2,430,099 worldwide 212 citations · 21 works
All ranked researchers at Linear Clinical Research

What are the most cited papers from Linear Clinical Research?

The most cited paper from Linear Clinical Research is "Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study" (Anthony R. Mato et al., 2021), with 471 citations. Next come "Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study" (462) and "Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial" (284).

Most cited papers
#PaperReleasedCitations
1 Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study Anthony R. Mato et al. · The Lancet Open access Mar 2021 471
2 Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study Lihua Elizabeth Budde, Laurie Helen Sehn, Matthew J. Matasar et al. · The Lancet Oncology Open access 5 Jul 2022 462
3 Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial Peter Richmond, Lara Hatchuel, Min Dong et al. · The Lancet Open access 29 Jan 2021 284
4 Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia Anthony R. Mato et al. · New England Journal of Medicine Open access 5 Jul 2023 232
5 Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study David M. O'Malley, Maryna Neffa, Bradley J. Monk et al. · Journal of Clinical Oncology Open access 21 Dec 2021 192
All 60 most cited papers, with filters and sorting

Which keywords describe research at Linear Clinical Research?

By fractional works in 2022-now, weighted toward what it does more of than the world: Rituximab, Lymphoma, Cancer Immunotherapy, Prognostic Factors, Chemotherapy, PET Imaging, Tumor Microenvironment and Immunotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 32 words, with their numbers
  1. Rituximab4▲ 95×2 topics
  2. Lymphoma4▲ 80×2 topics
  3. Cancer Immunotherapy3▲ 64×3 topics
  4. Prognostic Factors3▲ 22×9 topics
  5. Chemotherapy3▲ 13×13 topics
  6. Immunotherapy2▲ 12×13 topics
  7. PET Imaging2▲ 50×4 topics
  8. Tumor Microenvironment2▲ 18×7 topics
  9. Therapeutic Targets2▲ 52×5 topics
  10. Classification2▲ 16×2 topics
  11. Molecular Profiling2▲ 75×2 topics
  12. Genetic Pathogenesis2▲ 134×1 topic
  13. Hodgkin's Lymphoma2▲ 134×1 topic
  14. Inflammation2▲ 3.2×19 topics
  15. Chronic Lymphocytic Leukemia2▲ 160×1 topic
  16. Genomic Aberrations2▲ 160×1 topic
  17. Tumor Regression2▲ 55×2 topics
  18. Immune Checkpoint Blockade2▲ 53×1 topic
  19. PD-1 and PD-L12▲ 53×1 topic
  20. CAR T Cells2▲ 78×1 topic
  21. Chimeric Antigen Receptor2▲ 78×1 topic
  22. Cancer2▲ 3.9×21 topics
  23. Monoclonal Antibodies2▲ 59×2 topics
  24. Breast Cancer2▲ 20×5 topics
  25. Cancer Therapy2▲ 8.8×10 topics
  26. Fc Receptors2▲ 91×1 topic
  27. Glycosylation2▲ 46×2 topics
  28. Targeted Therapy2▲ 23×4 topics
  29. Therapeutic Antibodies2▲ 71×1 topic
  30. Clinical Trials1▲ 5.4×5 topics
  31. Epidemiology1◆ 0.91×16 topics
  32. Immunity1▲ 9.3×5 topics

Which research topics does Linear Clinical Research publish most on?

By volume in 2022-now: Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.

Lymphoma Diagnosis and Treatment: 2 fractional worksChronic Lymphocytic Leukemia Research: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksImmunotherapy and Immune Responses: 1 fractional worksHER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksCNS Lymphoma Diagnosis and Treatment: 1 fractional worksLung Cancer Treatments and Mutations: 1 fractional worksPhagocytosis and Immune Regulation: 0 fractional works
Pathology and Forensic MedicineGeneticsOncologyRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 2 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
  4. 4 CAR-T cell therapy research Oncology 2 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  6. 6 Immunotherapy and Immune Responses Immunology 1 works
  7. 7 HER2/EGFR in Cancer Research Oncology 1 works
  8. 8 CNS Lymphoma Diagnosis and Treatment Neurology 1 works
  9. 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  10. 10 Phagocytosis and Immune Regulation Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.0%not open52.0%

World: 40% of research is openly available.

with international co-authors58.6%domestic only41.4%

World: 18% is written across borders.

How has Linear Clinical Research's research output changed?

Output in 2022-2025 was 58% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Linear Clinical Research as a percentage of every work published that year, 0.000097% in 2024.

still counting0.00010%0.00020%0.00030%Linear Clinical Research0.00015% in 20251990200020102020

Fractional works of Linear Clinical Research over all fractional works that year. How the balance of science has shifted.

Other research institutions in Nedlands

All research institutions in Nedlands

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Linear Clinical Research. Posts are plain text and can be reported.